OverviewChartTechnicalNewsTraderScreen

APTOSE BIOSCIENCES INC/  CA03835T3091  /

Toronto
5/17/2024  9:59:47 PM Chg. -0.02 Volume Bid9:59:47 PM Ask9:59:47 PM High Low
1.61CAD -1.23% 12,500
Turnover: 20,044		 1.60Bid Size: 3,200 1.61Ask Size: 700 1.63 1.58
GlobeNewswire 5/14 Aptose Reports Results for the First Quarter 2024
GlobeNewswire 5/6 Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesda...
GlobeNewswire 3/26 Aptose Reports Results for the Fourth Quarter and Full Year 2023
GlobeNewswire 3/18 Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on ...
GlobeNewswire 1/31 Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement...
GlobeNewswire 1/26 Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placeme...
GlobeNewswire 12/10/2023 Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
GlobeNewswire 11/30/2023 Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
GlobeNewswire 11/9/2023 Aptose Reports Results for the Third Quarter 2023
GlobeNewswire 11/2/2023 Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
GlobeNewswire 10/30/2023 Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug ...
GlobeNewswire 10/26/2023 Aptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November...
GlobeNewswire 10/23/2023 Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
GlobeNewswire 10/16/2023 Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th Int...
GlobeNewswire 9/18/2023 Aptose to Present at the Cantor Global Healthcare Conference
GlobeNewswire 9/6/2023 Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
GlobeNewswire 8/24/2023 Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 3/22/2022 Aptose Reports Results for the Fourth Quarter and Full Year 2021
GlobeNewswire 3/8/2022 Aptose to Report Fourth Quarter and Full Year 2021 Financial Results and Hold Conference Call on Tue...
GlobeNewswire 3/1/2022 Aptose to Present at Oppenheimer’s 32nd Annual Healthcare Conference
GlobeNewswire 12/29/2021 Aptose to Participate in Two Biotech Events in January 2022
GlobeNewswire 12/20/2021 Aptose Provides Update on APTO-253 Program
GlobeNewswire 12/13/2021 HM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemia
GlobeNewswire 11/29/2021 Aptose to Hold Corporate Update Monday, December 13th
GlobeNewswire 11/22/2021 Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference